Keyword Search :
​​

Current Issue:

Volume 75-10

October 2014

Subscribe​​

Blogs

​​

Most Popular

Effectiveness of Integrated Care Including Therapeutic Assertive Community Treatment in Severe Schizophrenia Spectrum and Bipolar I Disorders: The 24-Month Follow-Up ACCESS II Study

Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

>>See all Most Popular

Podcast

​​​​

Publisher's Podcast: The Journal of ​Clinical Psychiatry Publisher’s Podcast

Features From the October 2014 Issue

>> Listen
>> See the table of contents
>> Subscribe to JCP Podcast
>> Subscribe to PCC Podcast
​​​​​​​​​​​​​​​​

Ahead of Print

Design and Rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) Study: A Novel Comparative Trial of Once-Monthly Paliperidone Palmitate Versus Daily Oral Antipsychotic Treatment for Delaying Time to Treatment #01#

Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial

Six-Month Outcomes From a Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure and Response Prevention or Risperidone in Adults With Obsessive-Compulsive Disorder

Escitalopram Treatment for Depressive Disorder Following Acute Coronary Syndrome: A 24-Week Double-Blind, Placebo-Controlled Trial

>>See all Online Ahead of Print

Featured

Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients

>> See entire article

Personality Modulates the Efficacy of Treatment in Patients With Major Depressive Disorder

>> See entire article

Education

​​

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

>>See entire activity >>See all Journal CME Feature​
​​​​​​​​​​​​​​

Current Standards of Treatment in MS and the Role of Oral Agents

>>See entire activity >>See all Electronic CME Feature

Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes

>>See entire activity      >>See all educational activities

Controversies in the Psycholopharmacology of Bipolar Disorder

>>See entire activity >>See all Psychlopedia

Special Sections

Switching Antipsychotic Medications to Reduce Adverse Event Burden in Schizophrenia: Establishing Evidence-Based Practice

>>See entire activity >>See all Academic Highlights

Mechanism of Action of Antipsychotic Medications

>>See entire activity

Prescribing Antidepressants for Bipolar Depression: What Does the Evidence Say?

>>See entire activity

The Role of the Extended Health Care Team in Successful LAI Therapy: Education to Overcome Barriers

>>See entire activity
>>See all Electronic Activities

Measurement-Based Strategies to Assess and Manage Schizophrenia

>>See entire activity >>See all Supplements